Diffusivity anisotropy signature of slowly expanding lesions predicts progression independent of relapse activity in

Alberto Calvi1, Francesc Vivó Pascual2, Elisabeth Solana2

  • 1Neuroimmunology and Multiple Sclerosis Unit and Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clinic Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain acalvi@clinic.cat.

Abstract

Insights

Slowly expanding lesions (SELs) in multiple sclerosis (MS) show greater microstructural damage. Their diffusion MRI signature, fractional anisotropy (FA), predicts progression independent of relapse activity (PIRA).

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Slowly expanding lesions (SELs) are linked to chronic active lesions in multiple sclerosis (MS).
  • SELs are associated with disease progression and disability.
  • Understanding SELs' spatial features is crucial for predicting MS outcomes.

Purpose of the Study:

  • To analyze the spatial characteristics of SELs using diffusion MRI.
  • To investigate the clinical impact of SELs on progression independent of relapse activity (PIRA).
  • To correlate microstructural changes in SELs with MS clinical progression.

Main Methods:

  • Observational study of MS patients with longitudinal MRI and clinical data.
  • Lesion categorization into definite SELs, possible SELs, and non-SELs using non-linear deformation.
  • Fractional anisotropy (FA) extraction from lesion cores and perilesional areas.
  • Statistical analysis including Mann-Whitney, mixed-effects, logistic, and Cox regression models.

Main Results:

  • Definite SELs (8% of lesions) showed significant FA decline over time in core and perilesional areas.
  • Longitudinal FA reduction in definite SELs correlated with worse MS Functional Composite (MSFC) scores.
  • FA changes in definite SELs were associated with higher odds of PIRA and predicted faster time to PIRA events.

Conclusions:

  • Definite SELs exhibit distinct microstructural damage compared to other lesions.
  • The FA signature of definite SELs is a potential imaging biomarker for MS progression.
  • SELs are significant contributors to PIRA in multiple sclerosis.

Related Concept Videos

Passive Diffusion: Overview and Kinetics01:17

Passive Diffusion: Overview and Kinetics

Passive diffusion is a critical process that allows small lipophilic drugs to cross the cell membrane along a concentration gradient. This mechanism's efficiency depends on four primary factors: the membrane's surface area, the drug's lipid-water partition coefficient, the concentration gradient, and the membrane's thickness.
When administered orally, drugs establish a substantial concentration gradient between the gastrointestinal (GI) lumen and the bloodstream, expediting...
711
Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
1.1K
Protein Diffusion in the Membrane01:24

Protein Diffusion in the Membrane

Proteins show rotational as well as lateral diffusion across the membrane. The lateral diffusion of proteins was confirmed through the cell fusion experiment where mouse and human cells were fused, resulting in hybrid cells. When the human and mouse cells fused, the specific membrane proteins on human and mouse cells were marked with the red and green-fluorescent markers, respectively. Initially, the red and green fluorescence was located on the respective hemisphere of the cell. As time...
4.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K